Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants
- 7 January 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 404 (1), 321-323
- https://doi.org/10.1016/j.bbrc.2010.11.115
Abstract
No abstract availableKeywords
Funding Information
- USPHS (NS36866)
This publication has 18 references indexed in Scilit:
- Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar SlicesThe American Journal of Pathology, 2010
- FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial CellsOnline Journal of Public Health Informatics, 2009
- Regulation and functions of sphingosine kinases in the brainBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neuronsJournal of Neurochemistry, 2008
- “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic TargetsPharmacological Reviews, 2008
- Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple SclerosisThe Journal of pharmacology and experimental therapeutics, 2007
- Oral Fingolimod (FTY720) for Relapsing Multiple SclerosisThe New England Journal of Medicine, 2006
- New insights on the use of desipramine as an inhibitor for acid ceramidaseFEBS Letters, 2006
- Cocaine induces a mixed lysosomal lipidosis in cultured fibroblasts, by inactivation of acid sphingomyelinase and inhibition of phospholipase A1Toxicology and Applied Pharmacology, 2003
- The Tricyclic Antidepressant Desipramine Causes Proteolytic Degradation of Lysosomal Sphingomyelinase in Human FibroblastsBiological Chemistry Hoppe-Seyler, 1994